Lydia Falk
About Lydia Falk
Lydia Falk is the Vice President at Nektar Therapeutics, where she has worked since 2018. She previously held the position of Assistant Vice President of Regulatory Affairs for Vaccines at Pfizer and earned her PhD in microbiology from the Uniformed Services University of the Health Sciences.
Work at Nektar Therapeutics
Lydia Falk has been serving as Vice President at Nektar Therapeutics since 2018. In this role, she contributes to the strategic direction and management of the company's operations. Prior to her current position, she held the title of Executive Director at Nektar Therapeutics starting in 2016. Her experience in the biopharmaceutical industry supports her leadership in advancing Nektar's mission in drug development and regulatory compliance.
Experience at Pfizer
Before joining Nektar Therapeutics, Lydia Falk worked at Pfizer as Assistant Vice President of Regulatory Affairs for Vaccines from 2009 to 2011. During her tenure, she focused on regulatory strategies and compliance for vaccine products. Her experience at Pfizer provided her with a solid foundation in regulatory affairs within the pharmaceutical industry.
Education and Expertise
Lydia Falk earned her PhD in Microbiology from the Uniformed Services University of the Health Sciences, where she studied from 1983 to 1998. Additionally, she holds a Bachelor of Science in Medical Technology from Douglass College, NJ. Her educational background equips her with extensive knowledge in microbiology and medical technology, which informs her work in the biopharmaceutical sector.
Professional Background
Lydia Falk has a diverse professional background in regulatory affairs and biopharmaceutical management. Her career spans over multiple years in significant roles, including her time at Pfizer and her ongoing leadership at Nektar Therapeutics. This experience has allowed her to develop a comprehensive understanding of the regulatory landscape and the complexities of drug development.